HemOnc Today 12.06.20 Biomarker predicts poor response to CAR-T, points way to personalized, gene-edited therapy Read
STAT+ 11.20.20 Cancer vaccine cocktail boosts immune response after melanoma surgery, research shows Read
SurvivorNet 10.28.20 Blood Test Could Predict the Best Type of Treatment for Metastatic Melanoma Read
Front Line Genomics 10.20.20 The international neoantigen initiative Tumour Neoantigen Selection Alliance (TESLA) has identified key parameters for immunotherapy advancement. Read
HemOnc Today 10.12.20 Hematology/oncology institutions, practices announce faculty promotions, additions Read
Endpoints News 10.09.20 Parker Institute summoned the neoantigen pioneers to compare their prediction algorithms. And they have some suggestions for the field Read
The ASCO Post 08.25.20 The Parker Institute for Cancer Immunotherapy Appoints John Connolly, PhD, as Chief Scientific Officer Read